Case Report

Reversal of Dabigatran Using Idarucizumab in a Septic Patient with Impaired Kidney Function in Real-Life Practice

Table 1

Coagulation tests.

ParameterStandard valuesBefore idarucizumab10 minutes after  g idarucizumab24 hours after idarucizumab

INR1.561.231.10
aPTT (sec)25.0–36.06130.241.5
Thrombin time (sec)11.5–19.4>12016.252.9
Fibrinogen (g/L)1.75–3.757.117.117.09
Dabigatran (ng/mL)119.05<30.0<30.0

Activated partial thromboplastin time (aPTT); international normalised ratio (INR).